NCT04529824View on ClinicalTrials.gov

Glucose Risk Assessment in Employer Populations

CompletedOBSERVATIONAL
Enrollment

207

Participants

Timeline

Start Date

April 1, 2019

Primary Completion Date

July 22, 2019

Study Completion Date

August 1, 2021

Conditions
DiabetesPre-diabetesGlucose Intolerance
Interventions
DEVICE

Dexcom G6 Continuous Glucose Monitor (CGM) System

Participants wear a blinded Dexcom G6 CGM and a Fitbit Charge 3 activity tracker for 10 days.

Trial Locations (1)

33803

Lakeland Clinic, Lakeland

All Listed Sponsors
lead

DexCom, Inc.

INDUSTRY

NCT04529824 - Glucose Risk Assessment in Employer Populations | Biotech Hunter | Biotech Hunter